Crinetics Pharmaceuticals, Inc. (CRNX)

43.44 -0.56 (-1.27%) USD  |  NASDAQ  |  Feb 20, 16:00
43.44 0.00 (0.00%) After-Hours: 20:00
More

Crinetics Pharmaceuticals Current Portion of Long Term Debt (Quarterly)

Current Portion of Long Term Debt (Quarterly) Chart

View Current Portion of Long Term Debt (Quarterly) for CRNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Portion of Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years

View Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Portion of Long Term Debt (Quarterly) Benchmarks

View Current Portion of Long Term Debt (Quarterly) Benchmarks
Start Trial
Madrigal Pharmaceuticals, Inc. Upgrade
GT Biopharma, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade
Sutro Biopharma, Inc. Upgrade
Gossamer Bio, Inc. Upgrade